文献速递其他结缔组织病

早期弥漫性皮肤型系统性硬化症皮肤评分变化与整体疾病严重度变化相关

Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

基于加拿大硬皮病研究组数据库,纳入154例和128例病程≤5年、无终末器官损害的早期dcSSc患者,随访1年和2年。2年时50%患者皮肤改善,其整体疾病严重度、医生整体评估、功能和生活质量均改善;皮肤变化与整体疾病严重度变化正相关。

要点

  • 早期dcSSc患者2年时50%皮肤改善,伴随整体疾病严重度和生活质量改善。
  • mRSS变化与整体疾病严重度变化正相关,支持其作为试验结局指标。
  • 病程≤3年亚组中关联相似。

核心结论

  • 在早期dcSSc患者中,1年和2年时整体疾病改善与皮肤改善平行。
  • mRSS变化与整体疾病严重度变化正相关,支持mRSS作为试验结局指标。

研究设计与样本

  • 基于加拿大硬皮病研究组数据库的队列分析,纳入154例和128例病程≤5年、无终末器官损害和/或显著合并症的早期dcSSc患者,随访1年和2年。

主要发现

  • 2年时64例(50%)患者皮肤改善(mRSS下降≥5分和/或≥25%)。
  • 皮肤改善者 summed DSS 改善(P=0.002),医生整体评估疾病活动度、严重度和损伤均改善(均P≤0.003),HAQ-DI改善(P=0.001),SF-36 PCS改善(P=0.005)。
  • mRSS变化与 summed DSS 变化正相关(P=0.006)。
  • 26例(20.3%)皮肤恶化(mRSS增加≥5分和/或≥25%),其 summed DSS 和医生整体评估更差(P=0.01和P≤0.009)。
  • 病程≤3年亚组中关联相似。

关键数值与推荐

  • 皮肤改善定义为mRSS下降≥5分和/或≥25%;皮肤恶化定义为mRSS增加≥5分和/或≥25%。
  • 疾病严重度采用不含皮肤域的 summed Medsger 疾病严重度评分(DSS)。

临床怎么用

  • 在早期dcSSc患者随访中,mRSS改善可反映整体疾病严重度、功能和生活质量的改善。
  • mRSS可作为早期dcSSc临床试验的结局指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether skin score changes are associated with changes in overall disease severity, function and quality of life in early dcSSc patients. METHODS: A total of 154 and 128 dcSSc patients from the Canadian Scleroderma Research Group database with 1 and 2 year follow-up and a disease duration ⩽5 years without end-stage organ damage and/or significant comorbidity at the initial visit were included. Skin was assessed using the modified Rodnan skin score (mRSS) and disease severity by the summed Medsger disease severity score (DSS) (without skin domain), physician and patient global assessments, function [HAQ disability index (HAQ-DI)] and quality of life [36-item Short Form Health Survey (SF-36) physical component summary (PCS)]. Analyses were repeated in patients with a disease duration ⩽3 years. RESULTS: At 2 years, 64 (50%) patients had improved skin (mRSS decrease of ⩾5 points and/or ⩾25%). Skin improvers had improved summed DSS (P = 0.002); better physician global assessments of disease activity, severity and damage (all P ⩽ 0.003); better HAQ-DI (P = 0.001) and SF-36 PCS (P = 0.005). Changes in the mRSS were positively correlated with changes in summed DSS (P = 0.006) and other disease outcomes. In the 26 (20.3%) patients with worsened skin (mRSS increase of ⩾5 points and/or ⩾25%), the summed DSS and physician global assessments were worse (P = 0.01 and P ⩽ 0.009, respectively). In the subgroup with a disease duration ⩽3 years, similar associations were found. CONCLUSION: At 1 and 2 years, overall disease improvement parallels skin improvement in early dcSSc. This is important for prognosis and reflects the value of mRSS as an outcome measure in trials with these patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zheng B, Nevskaya T, Baxter CA, et al. Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. Rheumatology (Oxford). 2020. PMID: 31359048. doi:10.1093/rheumatology/kez299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。